Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-02

Clinical Trial Update: Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine [NA]

View source ↗

Summary

A clinical trial evaluating combined occipital and trigeminal nerve stimulation (eCOT-NS) for preventive treatment of migraine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Neurolief Ltd. | Conditions: Migraine | NA | Status: WITHDRAWN